Glucolipid metabolism improvement in impaired glucose tolerance subjects consuming a Quinoa-based diet: a randomized parallel clinical trial

Purpose: To investigate the effects of quinoa on glucose and lipid metabolism, and the prognosis in people with impaired glucose tolerance.Methods: One hundred and thirty-eight patients diagnosed with impaired glucose tolerance following a glucose tolerance test in Guangzhou Cadre Health Management...

Full description

Bibliographic Details
Main Authors: Hongli Zeng, Xiangsheng Cai, Zhenyang Qiu, Yuchan Liang, Lu Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2023.1179587/full
_version_ 1797786681356582912
author Hongli Zeng
Xiangsheng Cai
Zhenyang Qiu
Yuchan Liang
Lu Huang
author_facet Hongli Zeng
Xiangsheng Cai
Zhenyang Qiu
Yuchan Liang
Lu Huang
author_sort Hongli Zeng
collection DOAJ
description Purpose: To investigate the effects of quinoa on glucose and lipid metabolism, and the prognosis in people with impaired glucose tolerance.Methods: One hundred and thirty-eight patients diagnosed with impaired glucose tolerance following a glucose tolerance test in Guangzhou Cadre Health Management Center were selected and randomly divided into quinoa intervention and control groups, according to the digital table method. After 1 year of follow-up, the differences in blood glucose, blood lipid, glycosylated hemoglobin and other indicators were compared. The disease prognosis between the two groups was also compared.Results: The 2 h postprandial blood glucose, glycosylated hemoglobin, insulin resistance index, total cholesterol, low-density lipoprotein cholesterol, body mass index, waist circumference, systolic and diastolic blood pressure after intervention in the quinoa group were significantly lower than before intervention. In contrast, high-density lipoprotein cholesterol was higher than before intervention and is statistically significant (p < 0.05). After 1 year of follow-up, the control group’s glycosylated hemoglobin and body mass index are higher than before intervention, and are statistically significant (p < 0.05). The 2 h postprandial blood glucose, glycosylated hemoglobin, insulin resistance index, body mass index, and mean diastolic blood pressure in the quinoa group are statistically significantly lower than in the control group, while high-density lipoprotein cholesterol is higher (p < 0.05). The rate of conversion to diabetes for participants in the quinoa group (7.8%) is statistically significantly lower than in the control group (20.3%) (χ2 = 12.760, p = 0.002). Logistic regression analysis showed that quinoa consumption is a protective factor against delaying the progression of diabetes (p < 0.05).Conclusion: Adding quinoa to staple food intake can reduce postprandial blood glucose, and improve lipid metabolism and insulin resistance, delaying the progression of diabetes in people with impaired glucose tolerance.
first_indexed 2024-03-13T01:11:20Z
format Article
id doaj.art-0d04851822b6475286e1afa852cae047
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-03-13T01:11:20Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-0d04851822b6475286e1afa852cae0472023-07-05T17:46:01ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2023-07-011410.3389/fphys.2023.11795871179587Glucolipid metabolism improvement in impaired glucose tolerance subjects consuming a Quinoa-based diet: a randomized parallel clinical trialHongli ZengXiangsheng CaiZhenyang QiuYuchan LiangLu HuangPurpose: To investigate the effects of quinoa on glucose and lipid metabolism, and the prognosis in people with impaired glucose tolerance.Methods: One hundred and thirty-eight patients diagnosed with impaired glucose tolerance following a glucose tolerance test in Guangzhou Cadre Health Management Center were selected and randomly divided into quinoa intervention and control groups, according to the digital table method. After 1 year of follow-up, the differences in blood glucose, blood lipid, glycosylated hemoglobin and other indicators were compared. The disease prognosis between the two groups was also compared.Results: The 2 h postprandial blood glucose, glycosylated hemoglobin, insulin resistance index, total cholesterol, low-density lipoprotein cholesterol, body mass index, waist circumference, systolic and diastolic blood pressure after intervention in the quinoa group were significantly lower than before intervention. In contrast, high-density lipoprotein cholesterol was higher than before intervention and is statistically significant (p < 0.05). After 1 year of follow-up, the control group’s glycosylated hemoglobin and body mass index are higher than before intervention, and are statistically significant (p < 0.05). The 2 h postprandial blood glucose, glycosylated hemoglobin, insulin resistance index, body mass index, and mean diastolic blood pressure in the quinoa group are statistically significantly lower than in the control group, while high-density lipoprotein cholesterol is higher (p < 0.05). The rate of conversion to diabetes for participants in the quinoa group (7.8%) is statistically significantly lower than in the control group (20.3%) (χ2 = 12.760, p = 0.002). Logistic regression analysis showed that quinoa consumption is a protective factor against delaying the progression of diabetes (p < 0.05).Conclusion: Adding quinoa to staple food intake can reduce postprandial blood glucose, and improve lipid metabolism and insulin resistance, delaying the progression of diabetes in people with impaired glucose tolerance.https://www.frontiersin.org/articles/10.3389/fphys.2023.1179587/fullquinoaimpaired glucose toleranceblood glucoseblood lipidinfluence
spellingShingle Hongli Zeng
Xiangsheng Cai
Zhenyang Qiu
Yuchan Liang
Lu Huang
Glucolipid metabolism improvement in impaired glucose tolerance subjects consuming a Quinoa-based diet: a randomized parallel clinical trial
Frontiers in Physiology
quinoa
impaired glucose tolerance
blood glucose
blood lipid
influence
title Glucolipid metabolism improvement in impaired glucose tolerance subjects consuming a Quinoa-based diet: a randomized parallel clinical trial
title_full Glucolipid metabolism improvement in impaired glucose tolerance subjects consuming a Quinoa-based diet: a randomized parallel clinical trial
title_fullStr Glucolipid metabolism improvement in impaired glucose tolerance subjects consuming a Quinoa-based diet: a randomized parallel clinical trial
title_full_unstemmed Glucolipid metabolism improvement in impaired glucose tolerance subjects consuming a Quinoa-based diet: a randomized parallel clinical trial
title_short Glucolipid metabolism improvement in impaired glucose tolerance subjects consuming a Quinoa-based diet: a randomized parallel clinical trial
title_sort glucolipid metabolism improvement in impaired glucose tolerance subjects consuming a quinoa based diet a randomized parallel clinical trial
topic quinoa
impaired glucose tolerance
blood glucose
blood lipid
influence
url https://www.frontiersin.org/articles/10.3389/fphys.2023.1179587/full
work_keys_str_mv AT honglizeng glucolipidmetabolismimprovementinimpairedglucosetolerancesubjectsconsumingaquinoabaseddietarandomizedparallelclinicaltrial
AT xiangshengcai glucolipidmetabolismimprovementinimpairedglucosetolerancesubjectsconsumingaquinoabaseddietarandomizedparallelclinicaltrial
AT zhenyangqiu glucolipidmetabolismimprovementinimpairedglucosetolerancesubjectsconsumingaquinoabaseddietarandomizedparallelclinicaltrial
AT yuchanliang glucolipidmetabolismimprovementinimpairedglucosetolerancesubjectsconsumingaquinoabaseddietarandomizedparallelclinicaltrial
AT luhuang glucolipidmetabolismimprovementinimpairedglucosetolerancesubjectsconsumingaquinoabaseddietarandomizedparallelclinicaltrial